MED.L Regulatory News (MED)

MedaPhor Group plc

("MedaPhor" or the "Group" or the "Company")

AGM Statement

MedaPhor Group plc (AIM: MED), the intelligent ultrasound software and simulation company, will hold its Annual General Meeting today at 10.30 a.m. at IP Group Offices, The Walbrook Building, 25 Walbrook, London, EC4N 8AF. At the meeting the Chairman, Riccardo Pigliucci, will make the following statement:

"The Group is trading in line with management's expectations, research and development work being undertaken by our Clinical Division is progressing well and Simulation Division sales in the UK and mainland Europe are showing good signs of recovery. Initial orders placed in our key territories for our recently launched BodyWorks point of care and emergency medicine simulator are also encouraging."

A copy of this announcement is available on the Group's website: www.medaphor.com

About MedaPhor (www.investors.medaphor.com)

MedaPhor (AIM: MED), the intelligent ultrasound software and simulation company, develops artificial intelligence-based clinical image analysis software tools, augmented reality-based needle guidance software and advanced hi-fidelity haptic and manikin-based training simulators for medical practitioners.

Based in Cardiff and Oxford in the UK and Atlanta in the US and Hong Kong in Asia, MedaPhor operates two divisions:

Intelligent Ultrasound Simulation Division 

Focuses on hi-fidelity ultrasound education and training through simulation. Its three main products are the ScanTrainer OBGYN and General Medical simulator training platform, the HeartWorks echocardiography simulator platform and the BodyWorks Eve Point of Care and Emergency Medicine Simulator. Over 500 MedaPhor simulators have been sold to over 300 medical institutions in over 30 countries around the world.

Intelligent Ultrasound Clinical Division

 Focuses on augmented reality and deep-learning based algorithms to make ultrasound machines smarter and more accessible. Products in development include ScanNav and NeedleGuide. ScanNav uses machine-learning based algorithms to automatically identify, grade and capture good ultrasound images. NeedleGuide aims to simplify ultrasound-guided needling by using deep learning and augmented reality to provide the user with pathway guidance and automated tracking for a range of medical procedures.

Some products in the pipeline may require US FDA approval, as such this material should be considered informational only and does not constitute an offer to sell or infer claims or benefits.